L Arendt-Nielsen Selected Research

Capsaicin (Zostrix)

1/2018	γ-Aminobutyric acid (GABA) oral rinse reduces capsaicin-induced burning mouth pain sensation: An experimental quantitative sensory testing study in healthy subjects.
7/2017	Antipruritic effect of pretreatment with topical capsaicin 8% on histamine- and cowhage-evoked itch in healthy volunteers: a randomized, vehicle-controlled, proof-of-concept trial.
1/2017	Histaminergic and non-histaminergic elicited itch is attenuated in capsaicin-evoked areas of allodynia and hyperalgesia: A healthy volunteer study.
10/2011	Effect of transdermal opioids in experimentally induced superficial, deep and hyperalgesic pain.
9/2010	The effects of training time, sensory loss and pain on human motor learning.
9/2010	A novel model of inflammatory pain in human skin involving topical application of sodium lauryl sulfate.
6/2010	Interactions of glutamate and capsaicin-evoked muscle pain on jaw motor functions of men.
1/2010	Effects of periodontal afferent inputs on corticomotor excitability in humans.
1/2010	The capsaicin cough reflex in patients with symptoms elicited by odorous chemicals.
7/2008	Interactions between glutamate and capsaicin in inducing muscle pain and sensitization in humans.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

L Arendt-Nielsen Research Topics

Disease

63	Pain (Aches) 01/2020 - 01/2000
22	Hyperalgesia 01/2018 - 01/2000
21	Myalgia 01/2017 - 01/2000
8	Knee Osteoarthritis 01/2019 - 09/2015
7	Osteoarthritis 01/2019 - 01/2014
6	Neurogenic Inflammation 07/2017 - 02/2003
5	Referred Pain 01/2005 - 01/2000
4	Inflammation (Inflammations) 01/2014 - 01/2003
3	Neuralgia (Stump Neuralgia) 08/2005 - 04/2001
3	Hypersensitivity (Allergy) 10/2004 - 01/2001
2	Low Back Pain (Lumbago) 01/2018 - 01/2017
2	Knee Injuries (Knee Injury) 01/2018 - 09/2015
2	Postoperative Pain 08/2014 - 09/2004
2	Facial Pain (Myofacial Pain) 01/2014 - 02/2011
2	Ganglion Cysts (Ganglion) 01/2014 - 05/2007
1	Hypertrophy 01/2019
1	Arthralgia (Joint Pain) 08/2018
1	Paresthesia (Dysesthesia) 01/2017
1	Fatigue 10/2014
1	Cold Hypersensitivity 03/2014
1	Polyneuropathies (Polyneuropathy) 03/2014
1	Hyperesthesia 09/2012
1	Burns 10/2011
1	Chronic Pain 10/2011
1	Asthma (Bronchial Asthma) 01/2010
1	Cough 01/2010
1	Eczema 01/2010
1	Multiple Chemical Sensitivity (Idiopathic Environmental Intolerance) 01/2010
1	Visceral Pain 10/2004

Drug/Important Bio-Agent (IBA)

26	Capsaicin (Zostrix)FDA Link 01/2018 - 01/2000
8	Analgesics (Analgesic Drugs)IBA 01/2018 - 10/2000
8	Glutamic Acid (Glutamate)FDA Link 01/2014 - 08/2001
6	Biomarkers (Surrogate Marker)IBA 01/2019 - 08/2001
5	Pharmaceutical PreparationsIBA 01/2018 - 09/2003
5	Histamine (Histamine Dihydrochloride)FDA Link 09/2017 - 10/2009
4	Lidocaine (Xylocaine)FDA LinkGeneric 01/2018 - 02/2000
4	Opioid Analgesics (Opioids)IBA 10/2011 - 10/2000
4	Ketamine FDA LinkGeneric 09/2004 - 02/2000
3	Nerve Growth Factor (NGF)IBA 01/2017 - 10/2011
3	Bee Venoms (Bee Venom)IBA 12/2009 - 01/2003
3	N-Methylaspartate (NMDA)IBA 05/2007 - 10/2000
3	Dihydrotachysterol (AT 10)IBA 02/2000 - 01/2000
2	gamma-Aminobutyric Acid (GABA)IBA 01/2018 - 01/2017
2	SolutionsIBA 01/2018 - 11/2001
2	Imipramine (Janimine)FDA LinkGeneric 01/2018 - 05/2001
2	AcidsIBA 01/2018 - 01/2017
2	Clobazam (HR 376)IBA 01/2018 - 01/2017
2	1-phenyl-3,3-dimethyltriazene (PDT)IBA 01/2017 - 01/2001
2	Menthol FDA Link 10/2014 - 03/2014
2	Fentanyl (Sublimaze)FDA LinkGeneric 10/2011 - 04/2003
2	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 05/2007 - 09/2003
2	Venlafaxine Hydrochloride (Effexor)FDA LinkGeneric 08/2005 - 04/2001
2	antineoplaston A10 (A 10)IBA 08/2004 - 06/2004
2	Alfentanil (Alfenta)FDA LinkGeneric 09/2003 - 07/2001
2	Serotonin (5 Hydroxytryptamine)IBA 04/2001 - 01/2000
1	EpitopesIBA 01/2019
1	Collagen Type XIBA 01/2019
1	aggrecanaseIBA 08/2018
1	Collagen Type III (Type III Collagen)IBA 08/2018
1	Oxycodone (Oxycontin)FDA LinkGeneric 01/2018
1	EnzymesIBA 01/2018
1	Aminobutyrates (Aminobutyric Acid)IBA 01/2018
1	Type A Botulinum Toxins (Botox)FDA Link 07/2017
1	Adenosine Diphosphate (ADP)IBA 07/2017
1	Tolterodine Tartrate (Detrol)FDA Link 01/2017
1	Acid Sensing Ion ChannelsIBA 01/2017
1	Protons (Proton)IBA 01/2017
1	BenzodiazepinesIBA 01/2017
1	Irritants (Vesicants)IBA 10/2014
1	catch-relaxing peptide (Mytilus)IBA 01/2014
1	CollagenIBA 01/2014
1	Matrix Metalloproteinases (MMPs)IBA 01/2014
1	C-Reactive ProteinIBA 01/2014
1	Adrenergic Receptors (Adrenergic Receptor)IBA 09/2012
1	Dexmedetomidine FDA Link 09/2012
1	Pain-FreeIBA 09/2012
1	Buprenorphine (Subutex)FDA LinkGeneric 10/2011
1	Opioid Receptors (Opioid Receptor)IBA 10/2011
1	Sodium Dodecyl Sulfate (Sodium Lauryl Sulfate)IBA 09/2010
1	PerfumeIBA 01/2010
1	Prostaglandins BIBA 12/2009
1	incobotulinumtoxinA FDA Link 10/2009
1	Estrogens (Estrogen)FDA Link 05/2007

Therapy/Procedure

10	Lasers (Laser) 09/2012 - 02/2003
8	Injections 01/2016 - 01/2000
7	Knee Replacement Arthroplasty (Total Knee Replacement) 01/2020 - 08/2014
5	Bite Force (Occlusal Forces) 06/2010 - 01/2000
4	Intradermal Injections 09/2003 - 02/2000
3	Diffuse Noxious Inhibitory Control 09/2012 - 01/2005
2	Activities of Daily Living (ADL) 01/2018 - 09/2015
2	Intramuscular Injections 04/2002 - 11/2001
1	Oral Administration 01/2018
1	Therapeutics 01/2018
1	Endurance Training 10/2014
1	Reoperation 08/2014
1	Replacement Arthroplasty 09/2012
1	Analgesia 12/2009
1	Electrodes (Electrode) 01/2005
1	Cholecystectomy 10/2004
1	Aftercare (After-Treatment) 10/2004